A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2011
08/23/2011	US8003648 Heterocyclic GPR40 modulators
08/23/2011	US8003635 Superoxide dismutase mimics for the treatment of ocular disorders and diseases
08/23/2011	US8003615 Stable vitamin B6 derivative
08/23/2011	US8003605 Administration of an insulin derivative having a substituent containing from 6 to 40 carbon atoms attached to one of its amino acid residues.
08/23/2011	US8003347 Nucleic acids encoding ChemerinR ligands
08/23/2011	US8003119 Composition for pharmaceutical or dietetic use for combating hair loss
08/23/2011	CA2627314C Composition for treating obesity comprising extract from white kidney beans, red kidney beans, and green tea leaves
08/23/2011	CA2532236C Pyridazinyl- piperazines and their use as histamine h3 receptor ligands
08/23/2011	CA2478186C Fluorinated 4-azasteroid derivatives as androgen receptor modulators
08/23/2011	CA2415414C Particulate vectors for improving oral absorption of active principles
08/23/2011	CA2358107C Shelf-stable formulation of glucagon-like peptide-1
08/23/2011	CA2335488C Conformationally constrained backbone cyclized somatostatin analogs
08/18/2011	WO2011100659A2 Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs
08/18/2011	WO2011100376A2 Methods and architecture for power optimization of iontophoretic transdermal drug delivery
08/18/2011	WO2011100197A1 Methods of treating glucose metabolism disorders
08/18/2011	WO2011099570A1 Age production inhibitor
08/18/2011	WO2011099526A1 Hydrogen-containing hypotonic biocompatible solution
08/18/2011	WO2011099514A1 Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism
08/18/2011	WO2011099502A1 Use of compound binding to msin3b that specifically binds to neuron restrictive silencer factor (nrsf)
08/18/2011	WO2011098990A1 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases
08/18/2011	WO2011098818A1 Dietary supplement composition
08/18/2011	WO2011098483A1 Pharmaceutical compositions comprising a combination of metformin and sitagliptin
08/18/2011	WO2011098262A2 P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth
08/18/2011	WO2011097750A1 Compositions, products, therapeutic uses and procedures for the production and/or crystallisation of extracts of encelia canescens lam (coronilla de fraile)
08/18/2011	WO2011080751A3 α4β2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
08/18/2011	WO2011043590A3 Pharmaceutical composition for treating diabetes or hypertension using taxus cuspidata and mulberry tree extracts, and method for preparing same
08/18/2011	WO2011041632A3 Combination therapies for the treatment of obesity
08/18/2011	WO2011038302A3 Insulin receptor binding antibodies
08/18/2011	WO2011011300A8 Differentiation of human embryonic stem cells
08/18/2011	US20110201673 Lpl variant therapeutics
08/18/2011	US20110201657 Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors
08/18/2011	US20110201656 Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
08/18/2011	US20110201654 Therapeutic combination
08/18/2011	US20110201640 Tricyclic compound
08/18/2011	US20110201632 2,5-Disubstituted Piperidine Orexin Rceptor Antagonists
08/18/2011	US20110201626 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
08/18/2011	US20110201624 Pharmaceutical Composition for Prevention and Treatment of Diabetes or Obesity Comprising a Compound that Inhibits Activity of Dipeptidyl Peptidase-IV, and other Antidiabetic or Antiobesity Agents as Active Ingredients
08/18/2011	US20110201623 Crystalline Form Of A Cyclopropyl Benzamide Derivative
08/18/2011	US20110201622 Solid Forms Comprising A Cyclopropyl Amide Derivative
08/18/2011	US20110201615 Triazole beta carboline derivatives as anti-diabetic agents
08/18/2011	US20110201612 Compositions for Modulating a Kinase Cascade and Methods of Use Thereof
08/18/2011	US20110201611 Process for the Preparation of Compositions for Modulating a Kinase Cascade and Methods of Use Thereof
08/18/2011	US20110201604 Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof
08/18/2011	US20110201591 Isonicotinamide orexin receptor antagonists
08/18/2011	US20110201590 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
08/18/2011	US20110201589 New bradykinin b1 antagonists
08/18/2011	US20110201579 Method of Improving the Overall Health of a Patient by Application of Pregnenolone
08/18/2011	US20110201574 Fatty acid amide hydrolase inhibitors
08/18/2011	US20110201565 Luteolin and diosmin/diosmetin as novel stat3 inhibitors for treating autism
08/18/2011	US20110201555 Novel estrogen receptor ligands
08/18/2011	US20110201551 Peptide having anti-diabetic activity and use thereof
08/18/2011	US20110201545 Gel based livestock feed, method of manufacture and use
08/18/2011	US20110201540 Glycosylation of Molecules
08/18/2011	US20110201539 Detecting succinylacetone
08/18/2011	US20110200672 Coated tablet formulation and method
08/18/2011	US20110200617 Combination therapy of beta-glycolipids and antibodies for the treatment of immune-related disorders
08/18/2011	US20110200613 Use of B Cell Expansion Agents in Generating Antibodies
08/18/2011	US20110200610 Immuno-Modulating Compositions for the Treatment of Immune-Mediated Disorders
08/18/2011	US20110200591 Products and methods to prevent infections
08/18/2011	US20110200587 Aminothiazolones as estrogen related receptor-alpha modulators
08/18/2011	US20110200586 Aminothiazolones as estrogen related receptor-alpha modulators
08/18/2011	US20110200580 Methods of treatment and prevention of diet-induced obesity and sequelae thereof
08/18/2011	US20110200579 Novel gene disruptions, compositions and methods relating thereto
08/18/2011	US20110200574 Use of proteases for gluten intolerance
08/18/2011	DE102004045186B4 Liposomen, die die intrazelluläre Penetration von Wirkstofen stimulieren, deren Verwendung zur Herstellung von topischen pharmazeutischen bzw. kosmetischen Zusammensetzungen, die diese Liposomen enthalten sowie ein Screening-Verfahren zum Auffinden von Substanzen zur Stimulierung der intrazellulären Penetration Liposomes, which stimulate the intracellular penetration of Wirkstofen, their use for the preparation of topical pharmaceutical and cosmetic compositions containing these liposomes as well as a screening method for finding substances for stimulating the intracellular penetration
08/18/2011	CA2788758A1 Treatment of a metabolic disorder
08/18/2011	CA2787727A1 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases
08/17/2011	EP2357200A1 Human antibodies that bind human TNFalpha
08/17/2011	EP2357193A1 Human GIL-19/AE289 proteins and polynucleotides encoding same
08/17/2011	EP2357173A1 New alkyne compounds with MCH-antagonistic activity and medicaments containing them
08/17/2011	EP2357009A1 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
08/17/2011	EP2357008A1 Albumin fusion proteins
08/17/2011	EP2357002A1 Nucleic acid molecules and polypeptides for immune modulation
08/17/2011	EP2356995A2 Process of preparation of formulations of the peptide Angiotensin-(1-7) and its analogues, agonists and antagonists using cyclodextrins, liposomes and biodegradable polymers and/or mixtures and products thereof
08/17/2011	EP2356994A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/17/2011	EP2356993A1 Medicament for the reduction of cholesterolemia and/or triglyceridemia
08/17/2011	EP2356987A1 Methods for purifying trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahydrocannabinol
08/17/2011	EP2356986A1 Composition for treatment of metabolic syndrome
08/17/2011	EP2356985A1 Novel pharmaceutical compositions comprising a combination of metformin and sitagliptin
08/17/2011	EP2356914A2 Composition for improving membrane composition and functioning of cells
08/17/2011	EP2356114A1 Aminoalkyl-substituted compounds as hif inhibitors
08/17/2011	EP2356112A1 Heteroaromatic compounds for use as hif inhibitors
08/17/2011	EP2355902A1 Nutritional compositions with coated lipid globules
08/17/2011	EP2355840A2 Chemoattractants inhibitors and the use thereof
08/17/2011	EP2355838A2 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
08/17/2011	EP2355814A2 Pyrones for the treatment of metabolic disorders
08/17/2011	EP2355813A1 Fat emulsion for artificially feeding seriously ill intensive care patients
08/17/2011	EP2355801A1 Statin nanoparticles
08/17/2011	EP1965810B1 Preparation for treatment of mineral deficiency
08/17/2011	EP1885717B1 Shp-2 inhibitors, pharmaceutical compositions comprising them and their use for treating phosphatase-mediated diseases
08/17/2011	EP1507558B1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
08/17/2011	EP1456419B1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
08/17/2011	EP1444233B1 A2b adenosine receptor antagonists
08/17/2011	EP1379507B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
08/17/2011	CN201928937U 桑叶除臭脱涩设备 Mulberry deodorant Deastringency equipment
08/17/2011	CN1829511B Use of telmisartan and amlodipine or Nifedipine in preparing medicine for increasing insulin sensitivity
08/17/2011	CN102159582A Oxazolopyrimidines as edg-1 receptor agonists
08/17/2011	CN102159573A Pyrazolo pyridine derivatives as nadph oxidase inhibitors
08/17/2011	CN102159572A Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
08/17/2011	CN102159566A Pyridone and pyridazone analogues as gpr119 modulators

1 ... 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 ... 1298